Acutus Medical, Inc. (AFIB)
| Market Cap | 1.41M |
| Revenue (ttm) | 20.16M |
| Net Income (ttm) | -9.55M |
| Shares Out | 29.91M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 574 |
| Average Volume | 24,776 |
| Open | 0.0425 |
| Previous Close | 0.0525 |
| Day's Range | 0.0425 - 0.0425 |
| 52-Week Range | 0.0250 - 0.2200 |
| Beta | -0.13 |
| RSI | 53.43 |
| Earnings Date | Mar 14, 2025 |
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. [Read more]
Financial Performance
In 2024, Acutus Medical's revenue was $20.16 million, an increase of 181.37% compared to the previous year's $7.16 million. Losses were -$9.55 million, -88.31% less than in 2023.
Financial StatementsNews
Acutus Medical GAAP EPS of -$0.32, revenue of $20.2M
Acutus Medical Reports Full Year 2024 Financial Results
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024.
Acutus Medical announces workforce reduction by 70%
Acutus Medical (AFIB) to reduce workforce by 70% and focus on supporting Medtronic products.
Acutus Medical Announces Operational Downsizing
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing.
Acutus Medical GAAP EPS of -$0.03
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.
Acutus Medical Reports First Quarter 2024 Financial Results
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024.
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Acutus Medical to Cancel Third Quarter 2023 Conference Call
CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company's announcement of its strategic realign...
Acutus Medical Reports Third Quarter 2023 Financial Results
CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023.
Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring.
Acutus Medical to Announce Third Quarter 2023 Financial Results
CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...
Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript
Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Conference Call August 7, 2023 4:30 AM ET Company Participants Caroline Corner - IR David Roman - CEO Takeo Mukai - CFO Conference Call Participant...
Acutus Medical Reports Second Quarter 2023 Financial Results
CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias a...
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...
Acutus Medical to Announce Second Quarter 2023 Financial Results
CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and ...
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
CARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and t...
Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript
Acutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer...
Acutus Medical Reports First Quarter 2023 Financial Results
CARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ar...
Acutus Medical to Announce First Quarter 2023 Financial Results
CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and...
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias ...
Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:14 PM ET Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Conference Call March 16, 2023, 16:30 PM ET Company Participants David Roman - President and CEO Takeo...